Updated: ImprimisRx's Approval And Superiority Claims For Compounded Drug Draw FDA Warning

 
• By Brenda Sandburg
  
Eye drop compounding
The US FDA objects to promotions for a compounded eye drop product. • Source: Shutterstock

More from Compliance

More from Pink Sheet